Home › Funds › Omega Fund Management, LLC › NUVB

Omega Fund Management, LLC position in NUVB

NUVATION BIO INC · Health Care

Omega Fund Management, LLC reported holding 8,081,089 shares of NUVB (NUVATION BIO INC) in its Q2 2026 13F filing — a position valued at US$45.9M, representing 24.72% of its reported portfolio and ranking #2 among its reported holdings. Omega Fund Management, LLC has disclosed NUVB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)8.08M sh
Reported value held$45.90M
Portfolio Weight24.72%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Omega Fund Management, LLC's NUVB position evolved

Omega Fund Management, LLC first disclosed a stake in NUVB in Q3 2023 at 15,072,340 shares (US$20.2M). The position peaked in Q4 2025 at 8,081,089 shares, worth US$72.4M. Across 12 filings, Omega Fund Management, LLC increased the stake 0 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 8,081,089 shares valued at US$45.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 15.07M $20.20M New
Q4 2023 15.07M $22.76M Hold
Q1 2024 14.07M $51.22M Reduce
Q2 2024 13.28M $38.77M Reduce
Q3 2024 13.07M $29.94M Reduce
Q4 2024 13.07M $34.77M Hold
Q1 2025 13.07M $23.01M Hold
Q2 2025 11.04M $21.53M Reduce
Q3 2025 8.83M $32.68M Reduce
Q4 2025 8.08M $72.41M Reduce
Q1 2026 8.08M $34.67M Hold
Q2 2026 8.08M $45.90M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 53 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Laurion Capital Management LP (US$44.4M), Context Capital Management, LLC (US$31.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has Omega Fund Management, LLC held NUVB?

Omega Fund Management, LLC has disclosed NUVB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Omega Fund Management, LLC's current position in NUVB?

As of Q2 2026, Omega Fund Management, LLC holds 8.08M shares of NUVB (NUVATION BIO INC), valued at $45.90M, representing 24.72% of its reported portfolio and ranking #2.

Has Omega Fund Management, LLC been buying or selling NUVB?

In the latest 13F filing (Q2 2026), Omega Fund Management, LLC held unchanged its position in NUVB. The position peaked in Q4 2025 at 8.08M shares.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Laurion Capital Management LP, Context Capital Management, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.